Cite
HARVARD Citation
Li, E. et al. (2021). Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia. JCO oncology practice. 17 (8), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, E. et al. (2021). Primary Prophylaxis With Biosimilar Filgrastim for Patients at Intermediate Risk for Febrile Neutropenia. JCO oncology practice. 17 (8), p. . [Online].